Pain Management After TKA: Comparison of Short- and Long-term Nerve Blocks
Anesthesia, Local, Pain, Postoperative
About this trial
This is an interventional treatment trial for Anesthesia, Local focused on measuring Total Knee Arthroplasty, Intra-articular Analgesia, Bupivacaine Hydrochloride
Eligibility Criteria
Inclusion Criteria:
- Age over 18 years
- Able to provide informed consent
- Undergoing elective total knee arthroplasty
- Able to tolerate both short- and long-term ON-Q therapy
Exclusion Criteria:
- Unable to provide informed consent
- History of dementia or mental instability
- Pregnancy
Sites / Locations
- Florida Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Short-term ON-Q
Long-term ON-Q
Single port, select-a-flow pump and ON-Q 750mL ball filled with bupivacaine 0.125% saphenous (adductor canal) nerve block and single port, fixed flow pump and 400mL ON-Q ball with bupivacaine 0.125% wide field posterior knee block to provide analgesia from surgery until medication has been depleted (typically 2-4 days)
Single port, select-a-flow pump and two 750mL ON-Q balls filled with bupivacaine 0.125% saphenous (adductor canal) nerve block and single port, fixed flow pump and two 400mL ON-Q ball with bupivacaine 0.125% wide field posterior knee block to provide analgesia from surgery up to 7 days post-operative. The second ball for each location will be provided pre-operatively, along with patient education for connection.